Etoricoxib: Phase II

In a dose-ranging Phase II trial of 398 patients with moderate to severe

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE